Current stock page

Financial Data

GKOS Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - DevicesScore data as of Nov 18, 2026

GKOSGlaukos Corporation

Healthcare / Medical - Devices

Leader

Strong Relative Position

BullishEdge 8/10
$233.08−$10.17 (−4.18%)

Latest quote

  • Momentum
    90
  • Value
    30
  • Quality
    64
  • Risk resilience
    57
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Latest Quarter at a Glance

Quarter ended Sep 30, 2026, compared with the same quarter a year earlier.

Revenue
$211.03M
+58.0% YoY
Net income
$2.02M
+112.4% YoY
Free cash flow
$36.49M
+411.2% YoY
Operating margin
0.4%
+12.6 pts YoY

Quarterly Financial Statements

Updated Nov 19, 2026.

GKOS, last 8 quarters. YoY compares the latest quarter with the same quarter a year earlier.

Income statement
Income statement, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Revenue+58.0%$211M$186M$151M$143M$134M$124M$107M$105M
Gross profit+71.8%$180M$152M$117M$111M$105M$97M$82M$77M
Operating income+105.1%$828K−$17M−$20M−$27M−$16M−$23M−$21M−$29M
Net income+112.4%$2M−$18M−$20M−$134M−$16M−$20M−$18M−$34M
EPS (diluted)+110.7%$0.03−$0.31−$0.34−$2.32−$0.28−$0.34−$0.32−$0.60
Gross margin+6.8 pts85.2%81.7%77.9%77.8%78.4%78.3%77.2%72.9%
Operating margin+12.6 pts0.4%-9.3%-13.2%-18.9%-12.3%-18.3%-19.4%-27.2%
Net margin+13.1 pts1.0%-9.9%-13.1%-93.4%-12.2%-15.8%-17.0%-31.8%
Cash flow
Cash flow, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Operating cash flow+482.3%$39M$15M−$13M$7M−$10M$7M−$19M$507K
Capital expenditure−27.2%−$2M−$3M−$4M−$3M−$2M−$1M−$2M−$2M
Free cash flow+411.2%$36M$12M−$16M$4M−$12M$6M−$20M−$1M
Free cash flow margin+26.1 pts17.3%6.5%-10.9%2.7%-8.8%4.7%-19.2%-1.2%
Balance sheet
Balance sheet, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets−2.0%$980M$921M$893M$893M$999M$987M$966M$975M
Total liabilities+14.1%$262M$238M$222M$237M$230M$222M$202M$208M
Shareholders' equity−6.8%$717M$682M$671M$656M$770M$765M$764M$767M
Total debt−2.2%$102M$103M$103M$140M$104M$105M$105M$103M
Cash and equivalents+65.2%$162M$114M$104M$91M$98M$101M$114M$170M
Valuation and ratios
Valuation and ratios, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
P/B ratio+8.9315.4813.8410.1110.546.556.546.199.00
Return on equity−12.3 pts-23.7%-27.6%-28.2%-28.6%-11.4%-12.1%-16.2%-19.1%
Debt to equity+0.010.140.150.150.210.140.140.140.13
Free cash flow yield+0.9 pts0.3%-0.1%-0.3%-0.3%-0.5%-0.5%-1.1%-1.0%

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
P/E ratio-82.74x
P/B ratio20.04x
Revenue growth (YoY)58.03%
EPS growth (YoY)110.71%
Gross margin81.13%
Operating margin-9.17%
ROE-24.91%
ROIC-7.22%
Debt to equity0.14
FCF yield0.25%

As of Nov 18, 2026

Technical indicators
MetricValue
Close
As of Nov 18, 2026
$233.08
Volume
As of Nov 13, 2026
546,461
RSI (14)
As of Nov 13, 2026
68.68
MACD
As of Nov 13, 2026
19.13
MACD signal
As of Nov 13, 2026
17
MACD histogram
As of Nov 13, 2026
2.13
ADX (14)
As of Nov 13, 2026
41.2
SMA (50)
As of Nov 13, 2026
$184.62
SMA (200)
As of Nov 13, 2026
$147.26
ATR (14)
As of Nov 13, 2026
$11.98
Historical volatility (annualized)
As of Nov 13, 2026
130.35%
Volume (20-day average)
As of Nov 13, 2026
1.9M
Risk measures
MetricValue
Resilience score57/100
Beta1.06
Annual volatility61.36%
Max drawdown-28.39%
Sharpe ratio1.83
VaR (95%, 1-day)-3.96%

As of Nov 18, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

GKOS Financial Data FAQ

What is Glaukos Corporation's revenue?

Glaukos Corporation's revenue is one of the core financial data points for GKOS. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Glaukos Corporation's revenue growing?

Revenue growth shows whether Glaukos Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is GKOS's EPS?

GKOS's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Glaukos Corporation's net income?

Glaukos Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Glaukos Corporation generate?

Free cash flow shows how much cash Glaukos Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Glaukos Corporation have?

Cash and debt help frame GKOS's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.